English  |  正體中文  |  简体中文  |  總筆數 :0  
造訪人次 :  52920454    線上人數 :  785
教育部委託研究計畫      計畫執行:國立臺灣大學圖書館
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
關於TAIR

瀏覽

消息

著作權

相關連結

"yu yun shao"的相關文件

回到依作者瀏覽
依題名排序 依日期排序

顯示項目 61-70 / 113 (共12頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目

機構 日期 題名 作者
臺大學術典藏 2020-04-10T12:16:04Z Comparative effectiveness of first-line platinum-based chemotherapy regimens for advanced lung squamous cell carcinoma Liao B.-C.;Yu-Yun Shao;Chen H.-M.;Shau W.-Y.;Lin Z.-Z.;Kuo R.N.;Lai C.-L.;Chen K.-H.;Cheng A.-L.;Yang J.C.-H.;Lai M.-S.; Liao B.-C.; YU-YUN SHAO; Chen H.-M.; Shau W.-Y.; Lin Z.-Z.; Kuo R.N.; Lai C.-L.; Chen K.-H.; Cheng A.-L.; Yang J.C.-H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:03Z The prognostic impact of type 2 diabetes mellitus on early cervical cancer in Asia Kuo H.-Y.;Lin Z.-Z.;Kuo R.;Shau W.-Y.;Lai C.-L.;Yang Y.-Y.;Yu-Yun Shao;Hsu C.;Cheng W.-F.;Cheng A.-L.;Yang J.C.H.;Lai M.-S.; Kuo H.-Y.; Lin Z.-Z.; Kuo R.; Shau W.-Y.; Lai C.-L.; Yang Y.-Y.; YU-YUN SHAO; Hsu C.; Cheng W.-F.; Cheng A.-L.; Yang J.C.H.; Lai M.-S.
臺大學術典藏 2020-04-10T12:16:03Z Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer Ho W.-C.; Tsai M.-H.; Feng W.-C.; Chow L.-P.; Hsu C.-H.; YU-YUN SHAO; Yeh C.-C.;Hsu C.-H.;Yu-Yun Shao;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.; Yeh C.-C.
臺大學術典藏 2020-04-10T12:16:03Z Treatment efficacy differences of sorafenib for advanced hepatocellular carcinoma: A meta-analysis of randomized clinical trials Chan S.-Y.; Shau W.-Y.; YU-YUN SHAO; Yu-Yun Shao;Shau W.-Y.;Chan S.-Y.;Lu L.-C.;Hsu C.-H.;Cheng A.-L.; Lu L.-C.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z Predictive biomarkers of sorafenib efficacy in advanced hepatocellular carcinoma: Are we getting there? Yu-Yun Shao;Hsu C.-H.;Cheng A.-L.; YU-YUN SHAO; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z High serum transforming growth factor-β1 levels predict outcome in hepatocellular carcinoma patients treated with sorafenib Lin T.-H.;Yu-Yun Shao;Chan S.-Y.;Huang C.-Y.;Hsu C.-H.;Cheng A.-L.; Lin T.-H.; YU-YUN SHAO; Chan S.-Y.; Huang C.-Y.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:02Z Statin Use Is Associated With Improved Prognosis of Colorectal Cancer in Taiwan Yeh Y.-C.; Lai C.-L.; Lin Z.-Z.; Cheng A.-L.; Lai M.-S.; Yu-Yun Shao;Hsu C.-H.;Yeh K.-H.;Chen H.-M.;Yeh Y.-C.;Lai C.-L.;Lin Z.-Z.;Cheng A.-L.;Lai M.-S.; YU-YUN SHAO; Hsu C.-H.; Yeh K.-H.; Chen H.-M.
臺大學術典藏 2020-04-10T12:16:01Z Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma YU-YUN SHAO; Liu T.-H.; Lee Y.-H.; Hsu C.-H.; Cheng A.-L.
臺大學術典藏 2020-04-10T12:16:01Z Key opioid prescription concerns in cancer patients: A nationwide study Fu W.-M.; Chen H.-M.; Lee Y.-H.; Lai M.-S.; YU-YUN SHAO; Hsu C.-H.; Lin C.-P.; Lin C.-P.;Hsu C.-H.;Fu W.-M.;Chen H.-M.;Lee Y.-H.;Lai M.-S.;Yu-Yun Shao
臺大學術典藏 2020-04-10T12:16:01Z Cyclin E1 inhibition can overcome sorafenib resistance in hepatocellular carcinoma cells through Mcl-1 suppression Hsu C.; Lin L.-I.; Cheng Y.-C.; Feng Z.-R.; YU-YUN SHAO; Cheng A.-L.; Ou D.-L.

顯示項目 61-70 / 113 (共12頁)
<< < 2 3 4 5 6 7 8 9 10 11 > >>
每頁顯示[10|25|50]項目